LifeTech Scientific Corporation
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac P… Read more
Market Cap & Net Worth: LifeTech Scientific Corporation (LFTSF)
LifeTech Scientific Corporation (PINK:LFTSF) has a market capitalization of $1.03 Billion ($1.03 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #8026 globally and #4130 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LifeTech Scientific Corporation's stock price $0.23 by its total outstanding shares 4400767400 (4.40 Billion).
LifeTech Scientific Corporation Market Cap History: 2021 to 2025
LifeTech Scientific Corporation's market capitalization history from 2021 to 2025. Data shows change from $2.86 Billion to $1.03 Billion (-23.78% CAGR).
LifeTech Scientific Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LifeTech Scientific Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.79x
LifeTech Scientific Corporation's market cap is 0.79 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
4.62x
LifeTech Scientific Corporation's market cap is 4.62 times its annual earnings
1.97x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $2.86 Billion | $925.33 Million | $292.47 Million | 3.09x | 9.78x |
| 2022 | $1.50 Billion | $1.10 Billion | $325.34 Million | 1.36x | 4.60x |
| 2023 | $1.50 Billion | $1.27 Billion | $263.24 Million | 1.18x | 5.68x |
| 2024 | $1.03 Billion | $1.30 Billion | $222.39 Million | 0.79x | 4.62x |
Competitor Companies of LFTSF by Market Capitalization
Companies near LifeTech Scientific Corporation in the global market cap rankings as of March 18, 2026.
Key companies related to LifeTech Scientific Corporation by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
LifeTech Scientific Corporation Historical Marketcap From 2021 to 2025
Between 2021 and today, LifeTech Scientific Corporation's market cap moved from $2.86 Billion to $ 1.03 Billion, with a yearly change of -23.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.03 Billion | 0.00% |
| 2024 | $1.03 Billion | -31.32% |
| 2023 | $1.50 Billion | 0.00% |
| 2022 | $1.50 Billion | -47.69% |
| 2021 | $2.86 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of LifeTech Scientific Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.03 Billion USD |
| MoneyControl | $1.03 Billion USD |
| MarketWatch | $1.03 Billion USD |
| marketcap.company | $1.03 Billion USD |
| Reuters | $1.03 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.